Introduced by Consumer Technology Association VP of Regulatory Affairs David Grossman, FDA Commissioner Robert Califf took the CES stage with interviewer Lisa Dwyer, a partner at international law firm King & Spalding. Califf noted the monumental differences in technology that have taken place between his first stint at the Food & Drug Administration in 2015 and today. “The changes are so dramatic, it’s hard to characterize them,” he said. “We’re moving into a different world.” He’s excited about “the hundreds of products with AI” that can bring so much good to the market but also noted the potential harms. Continue reading CES: FDA Commissioner Robert Califf on Bias in Healthcare